Actively Recruiting
Leveraging Implementation Science and Design Methods to Sustain Community-based Mental Health Services for Refugees
Led by University of Illinois at Chicago ยท Updated on 2025-10-01
74
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
Sponsors
U
University of Illinois at Chicago
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a peer-led family and social strengthening group intervention called CAFES2 for refugee families. This pilot randomized trial uses a hybrid type 1 effectiveness-implementation design to study the feasibility, acceptability, and preliminary effectiveness of CAFES2, which addresses the complex mental health and social needs of refugee families from Arabic-speaking countries. The study aims to generate knowledge on family-based mental health support and implementation strategies for peer providers in community settings. The CAFES2 intervention includes an initial home visit followed by six multiple-family group sessions led by refugee peers. These sessions focus on family stressors, psychoeducation about trauma and displacement, emotion regulation, family and social strengths, family identity, and community resources. Families in the intervention group participate in these sessions in addition to any other services they are receiving. Families in the control group continue their usual care and receive healthy lifestyle materials. Participants include families with at least one adult caregiver and one child aged 12 or older, living together in Chicago for less than three years. Researchers will assess mental health symptoms, family and social support, and intervention feasibility and acceptability through questionnaires at baseline, immediately after the intervention, and at a six-week follow-up. The study includes ongoing monitoring of participant experiences and fidelity of the peer-led model. Total study duration extends through August 2026.
CONDITIONS
Brief Title
Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Family is from Iraq, Syria, Lebanon, Jordan, Palestine, or Yemen
- Refugee family living in Chicago for less than three years
- Household includes at least one adult caregiver aged 18 to 55 and one child aged 12 or older
- One family member scores greater than 3 on the GHQ-12
- Able to provide written informed consent
You will not qualify if you...
- Not from an Arabic-speaking country in the Middle East (Iraq, Syria, Jordan, Lebanon, Palestine, Yemen)
- No child aged 12 or older living with the family in one household
- Arrived in the U.S. as a refugee more than three years ago
- Developmental disabilities that prevent participation in the intervention
- Severe mental health issues (e.g., suicidality, psychotic disorder), active substance use, or current family crisis (e.g., domestic violence, divorce proceedings)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of the intervention period
Participants in the intervention group receive an initial home visit and participate in six multiple family group sessions led by peer providers, focusing on family and social strengthening. Participants in the control group continue with their usual care and receive healthy lifestyle materials.
1 home visit and 6 group sessions
Duration - 6 weeks after intervention
Participants are followed up to assess mental health outcomes, family support, and intervention acceptability after completing the intervention.
1 follow-up visit
Trial Site Locations
Total: 1 location
1
University of Illinios Chicago
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
M
Mary Bunn, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here